Passing to the limit 2D-1D in a model for metastatic growth

Journal of Biological Dynamics

Volumn 6, Issue SUPPL. 1, 2012, Pages 19-30

  Benzekry, Sebastien ^a,b  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b Laboratoire de Toxicocinétique et Pharmacocinétique UMR MD3   (France)

Author keywords

angiogenesis; cancer modelling; structured population dynamics

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; CELL PROLIFERATION; COMPUTER SIMULATION; HUMAN; METASTASIS; PATHOLOGY;

CELL PROLIFERATION; COMPUTER SIMULATION; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS;

EID: 84855934545     PISSN: 17513758     EISSN: 17513766     Source Type: Journal    
DOI: 10.1080/17513758.2011.568071     Document Type: Article

References (18)

1. Barbolosi, D., Benabdallah, A., Hubert, F. and Verga, F. 2009. Mathematical and numerical analysis for a model of growing metastatic tumors. Math. Biosci., 218: 1-14.
2. Barbolosi, D. and Iliadis, A. 2001. Optimizing drug regimens in cancer chemotherapy: A simulation study using a PKPD model. Comput. Biol. Med., 31: 157-172.
3. Benzekry, S. 2010. "Mathematical and numerical analysis of a model for anti-angiogenic therapy in metastatic cancers". submitted for publication Available athttp://hal.archives-ouvertes.fr/hal-00518110/fr/
4. Benzekry, S. 2011. Mathematical analysis of a two-dimensional population model of metastatic growth including angiogenesis. J. Evol. Equations, 11: 187-213.
5. Billy, F., Ribba, B., Saut, O., Morre-Trouilhet, H., Colin, T., Bresch, D., Boissel, J., Grenier, E. and Flandrois, J. 2009. A pharmacologically based multiscale mathematical model of angiogenesis and its use in investigating the efficacy of a new cancer treatment strategy. J. Theoret. Biol., 260: 545-562.
6. Devys, A., Goudon, T. and Laffitte, P. 2009. A model describing the growth and the size distribution of multiple metastatic tumors. Discrete Contin. Dyn. Syst. Ser., B 12: 731-767.
7. d'Onofrio, A. and Gandolfi, A. 2004. Tumour eradication by antiangiogenic therapy: Analysis and extensions of the model by Hahnfeldt et al. (1999). Math. Biosci., 191: 159-184.
8. d'Onofrio, A., Ledzewicz, U., Maurer, H. and Schttler, H. 2009. On optimal delivery of combination therapy for tumors. Math. Biosci., 222: 13-26.
9. Ebos, J. M.L., Lee, C. R., Cruz-Munoz, W., Bjarnason, G. A., Christensen, J. G. and Kerbel, R. S. 2009. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell, 15: 232-239.
10. Folkman, J. 1972. Antiangiogenesis: New concept for therapy of solid tumors. Ann. Surg., 175: 409-416.
11. Hahnfeldt, P., Panigraphy, D., Folkman, J. and Hlatky, L. 1999. Tumor development under angiogenic signaling: A dynamical theory of tumor growth, treatment, response and postvascular dormancy. Cancer Res., 59: 4770-4775.
12. Harris, J., Morrow, M. and Norton, L. 1997. "Malignant tumors of the breast". In Cancer: Principles and Practice of Oncology, 5, Edited by: DeVita, J. V., Hellman, S. and Rosenberg, S. 1557-1602. Philadelphia: Lippincott-Raven.
13. Hinow, P., Gerlee, P., McCawley, L. J., Quaranta, V., Ciobanu, M., Wang, S., Graham, J. M., Ayati, B. P., Claridge, J., Swanson, K. R., Loveless, M. and Anderson, A. R. 2009. A spatial model of tumor-host interaction: Application of chemotherapy. Math. Biosci. Eng., 6: 521-545.
14. Iwata, K., Kawasaki, K. and Shigesada, N. 2000. A dynamical model for the growth and size distribution of multiple metastatic tumors. J. Theoret. Biol., 203: 177-186.
15. Paez-Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Vinals, F., Inoue, M., Bergers, G., Hanahan, D. and Casanovas, O. 2009. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell, 15: 220-231.
16. Perthame, B. 2007. "Transport Equations in Biology, Frontiers in Mathematics". Basel: Birkhaser.
17. Riely, G. J., Rizvi, N. A., Kris, M. G., Milton, D. T., Solit, D. B., Rosen, N., Senturk, E., Azzoli, C. G., Brahmer, J. R.Sirotnak, F. M. 2009. Randomized phase II study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancer. J. Clin. Oncol., 27: 264-270.
18. Swan, G. W. 1990. Applications of optimal control theory in biomedicine. Math. Biosc., 101: 237-284.